FeesSafety
Pluang+

Cambria Endowment Style ETF (ENDW) rated Buy for low-cost, diversified portfolio with strong returns since 2025

Analyst Insights
18 Nov 2026, 13:40 WIB
Seeking Alpha
View Source
Bullish
Cambria Endowment Style ETF (ENDW) rated Buy for low-cost, diversified portfolio with strong returns since 2025

The Cambria Endowment Style ETF (ENDW) is recommended as a Buy for investors seeking a low-cost, one-ticker permanent portfolio solution. Since its inception in April 2025, ENDW has outperformed traditional 60/40 and 80/20 portfolios on both total and risk-adjusted returns. The fund uses leverage to maintain a diversified mix of equities, bonds, and alternatives, effectively resembling a 60/40/20 portfolio. This makes it suitable for moderate investors, with flexibility for more aggressive or conservative allocations.

The Cambria Endowment Style ETF (ENDW) is highlighted here with Pluang's market data as context. For readers following US stocks on Pluang, as of Nov 18, 2026 18:02 WIB, 87 of 150 priced stocks rose while 59 fell. Notable movers include TSM at USD 371.55 with a 3.30% increase, HPE at USD 47.59 up 3.28%, and SPCE at USD 1.34 rising 3.08%.

More News

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft's stock fell 2.27% to $506.24 following global outages affecting its Copilot, Teams, and Outlook services. The outages, attributed to server issues rather than cyberattacks, raised concerns amid broader software sector weakness. Oppenheimer...

Market News
Bearish
49 minutes ago
Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target Corporation reported earnings per share of $2.65, beating estimates of $2.08, and revenue of $27.1 billion, surpassing the $26.5 billion forecast. The company achieved its strongest quarterly sales growth in about five years, with net sales up...

Company Fundamentals
Bullish
55 minutes ago
Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics announced its participation in the Piper Sandler 38th Annual Healthcare Conference from December 1-3, 2026, in New York City. CEO Daniel Barber will present on December 2 at 10:30 am ET, with one-on-one investor meetings schedu...

Market News
Neutral
1 hour ago
Raymond James upgrades Charles Schwab to Strong Buy as client assets hit $13.27T in Oct 2026

Raymond James upgrades Charles Schwab to Strong Buy as client assets hit $13.27T in Oct 2026

Raymond James upgraded Charles Schwab to Strong Buy following strong growth in October 2026. Client assets rose 12% year over year to $13.27 trillion, with core net new assets surging 50% to $66.5 billion, a record for the month. Schwab also opened 4...

Analyst Insights
Bullish
2 hours ago
SDVerse named CES Innovation Awards 2027 Honoree for AI-powered automotive software marketplace.

SDVerse named CES Innovation Awards 2027 Honoree for AI-powered automotive software marketplace.

SDVerse, a B2B automotive software marketplace founded by General Motors, Magna, and Wipro, was honored with a CES Innovation Award 2027 in the Enterprise Tech category. The platform uses AI and standardized technical data to help automakers and supp...

Others
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App